inflammation of the colonic mucosa characterized by massive immune cell infiltration (macrophages, T cells, B cells, dendritic cells, neutrophils), disrupted gut barrier integrity, and loss of immune tolerance to commensal gut microbiome. Can manifest as acute (infectious, self-limiting) or chronic (Ulcerative Colitis, inflammatory bowel disease), with chronic forms representing persistent failure of inflammatory resolution mechanisms and ongoing gut dysbiosis.
Imagine your colon as a peaceful border town where locals (commensal bacteria) and border guards (immune cells) have lived in harmony for years under a carefully negotiated treaty (immune tolerance). One day, the treaty breaks down β maybe a few troublemakers crossed the border (pathogenic bacteria), or the border wall developed cracks (leaky gut), or the guard commander went rogue (loss of Treg function). Now the guards see every local as a potential threat. They call in reinforcements: neutrophils arrive like riot police spraying tear gas (reactive oxygen species), macrophages set up roadblocks, and the whole town becomes a war zone. Buildings burn (epithelial damage), supply lines collapse (nutrient malabsorption), and the conflict becomes self-perpetuating β the destruction itself recruits more guards, who cause more destruction. The brain's intelligence agency (insular cortex) files detailed reports of this conflict, creating an "immunengram" β a memory pattern so precise that merely showing the agency similar intelligence photos (conditioned stimuli) can reactivate the entire conflict response, even when the original threat is long gone.
Colitis pathogenesis involves a multi-step breakdown of intestinal homeostasis:
Initiation Phase:
- Barrier disruption β PAMPs and DAMPs exposure β TLR4 and NOD-Like Receptors activation on intestinal epithelial cells and resident dendritic cells
- Dendritic cell activation β migration to mesenteric lymph nodes β presentation of microbial antigens to naive T cells
- Loss of Treg suppression (β IL-10, β TGF-beta) β unopposed Th1 and Th17 differentiation
- Th1 cells produce IFN-Ξ³ β activates M1 macrophages β amplification of TNF-Ξ±, IL-1Ξ², Interleukin-6
- Th17 cells produce IL-17 and IL-22 β epithelial CXCL1 and CXCL8 secretion β massive neutrophil recruitment
Amplification Cascade:
graph TD
A[Barrier Breach] --> B[TLR4/NOD activation]
B --> C[Dendritic Cell Activation]
C --> D[Loss of Treg Control]
D --> E[Th1 Differentiation]
D --> F[Th17 Differentiation]
E --> G["IFN-Ξ³ Production"]
F --> H[IL-17/IL-22 Production]
G --> I[M1 Macrophage Activation]
H --> J[Neutrophil Recruitment via CXCL1/8]
I --> K["TNF-Ξ±/IL-1Ξ²/IL-6 Release"]
J --> L[ROS and Protease Damage]
K --> M[Epithelial Apoptosis]
L --> M
M --> N[Further Barrier Damage]
N --> A
Cellular Infiltration Pattern:
- Neutrophils: 60-80% of infiltrate in active disease β release myeloperoxidase, elastase, reactive oxygen species β crypt abscess formation
- M1 Macrophages: express iNOS β nitric oxide production β nitrosative stress β epithelial DNA damage
- T cells: expanded CD4+ effector populations (Th1>Th17) β chronic antigen stimulation β tissue-resident memory formation
- B cells: plasma cell expansion β autoantibody production (anti-neutrophil cytoplasmic antibodies in some cases)
- Dendritic cells: sustained presentation β loss of tolerogenic phenotype β perpetuation of effector responses
Cytokine Network:
Brain-Immune Memory Formation:
- Insular cortex integrates visceral signals (vagal afferents), immune signals (cytokines crossing blood-brain barrier at circumventricular organs), and contextual cues
- Repeated colitis episodes β synaptic strengthening in insula-amygdala-hypothalamus circuits
- Immunengram formation: pattern of immune activation becomes retrievable memory trace
- Conditioned reactivation: neutral stimuli (saccharin taste, context) paired with colitis can later trigger immune response independent of antigen β demonstrated in mouse models with DSS-induced colitis
Resolution Failure:
Diagnostic Utility:
- Calprotectin (fecal neutrophil-derived protein): >50 mg/kg indicates active intestinal inflammation; >250 mg/kg strongly suggests IBD; correlates with endoscopic disease activity
- Elevated CRP (>10 mg/L) and ESR during flares, though normal values don't exclude active disease
- Fecal lactoferrin and S100A12 as alternative inflammatory markers
cPNI Framework Integration:
- Metamodel 0 (evolutionary mismatch): modern low-fiber, high-processed food diet β loss of ancestral microbial diversity β breakdown of oral tolerance mechanisms that co-evolved with hunter-gatherer microbiome
- Metamodel 1 (psychosocial stress): chronic stress β HPA axis dysregulation β glucocorticoid resistance β failure of anti-inflammatory feedback; stress-induced sympathetic activation β altered gut motility and permeability
- Selfish Immune System: immune response protects against pathogens but at metabolic cost β chronic colitis diverts resources from muscle, bone, cognition (explains IBD-associated fatigue, cognitive dysfunction)
- Immunoception: colitis serves as experimental model proving brain can "learn" immune states and reactivate them via conditioned pathways β critical for understanding psychosomatic triggers in IBD patients
Clinical Intervention Targets:
- Barrier restoration: zinc carnosine, L-glutamine, curcumin, colostrum β tight junction repair
- Microbiome restoration: Faecalibacterium prausnitzii, Akkermansia-muciniphila, Bifidobacterium infantis β SCFA production and mucus support
- Resolution promotion: high-dose EPA/DHA β SPM substrate; direct SPM supplementation (RvD1, MaR1)
- Cytokine blockade: anti-TNF biologics (infliximab) for severe cases; curcumin as natural NF-ΞΊB inhibitor
- Vagal tone: meditation, breathing exercises β enhanced cholinergic anti-inflammatory pathway
- Brain-immune decoupling: cognitive-behavioral interventions to address conditioned exacerbation patterns
Patient Populations:
- IBD patients (ulcerative colitis, Crohn's with colonic involvement)
- Post-infectious IBS with persistent low-grade inflammation
- Microscopic colitis (lymphocytic/collagenous)
- NSAID-induced colonic injury
- Stress-reactive bowel symptoms with inflammatory component
Evolutionary Context:
Modern hygiene, antibiotics, cesarean delivery β reduced early-life microbial exposure β impaired Treg development β increased autoimmune/inflammatory disease risk (hygiene hypothesis). Hunter-gatherer populations with high parasitic load show robust Treg function and near-zero IBD incidence.
- Colitis used in landmark immunoception studies (Ader & Cohen lineage) demonstrating conditioned immune responses retrievable by brain
- Fecal calprotectin >50 mg/kg = 93% sensitivity, 96% specificity for distinguishing IBD from IBS
- Neutrophil-to-lymphocyte ratio >3 correlates with active colitis and poor prognosis
- TNF-Ξ± levels in colonic tissue 10-100x higher than serum during active disease
- Butyrate-producing bacteria (F. prausnitzii) depleted by 70-90% in active IBD vs healthy controls
- IL-6 >10 pg/mL in peripheral blood predicts steroid resistance in acute severe colitis
- Brain insular cortex shows thickening on MRI in chronic IBD patients β neural adaptation to chronic visceral pain signals
- Saccharin-paired colitis induction β conditioned colitis response in 60-80% of mice upon saccharin re-exposure alone
- Resolvin D1 levels inversely correlate with disease activity; RvD1 supplementation reduces colitis severity by 40-60% in animal models
- Vagus nerve stimulation reduces colitis severity via Ξ±7 nicotinic acetylcholine receptor on macrophages β suppression of TNF-Ξ± release
- immunoception β colitis paradigm proves brain can sense, encode, and retrieve specific immune activation patterns
- immunengram β stored neural representation of colitis-specific immune response in insular cortex circuitry
- insular cortex β neural substrate integrating visceral, immune, and contextual information during colitis episodes
- conditioned immune response β colitis can be triggered by learned cues (taste, context) independent of actual pathogen exposure
- gut dysbiosis β altered microbiome composition (loss of Faecalibacterium, Akkermansia) both triggers and perpetuates colitis
- inflammatory bowel disease β chronic colitis represents core IBD pathology with failed resolution mechanisms
- Ulcerative Colitis β archetypal chronic colitis limited to colon with continuous mucosal inflammation
- immune tolerance β colitis arises from breakdown of oral tolerance to commensal bacteria
- Th1 β IFN-Ξ³-producing subset driving tissue destruction via macrophage activation in colitis
- Th17 β IL-17/IL-22-producing cells recruiting neutrophils and perpetuating inflammation
- Treg β regulatory T cell failure to suppress effector responses underlies loss of tolerance
- TNF-Ξ± β master proinflammatory cytokine; anti-TNF biologics induce remission in 60% of IBD patients
- IL-1Ξ² β inflammasome-derived cytokine amplifying epithelial damage and neutrophil recruitment
- Interleukin-6 β drives Th17 differentiation, acute phase response, and predicts steroid resistance
- IL-10 β anti-inflammatory cytokine deficiency permits unchecked Th1/Th17 responses
- neutrophils β primary tissue-destructive cells releasing proteases, ROS, and forming crypt abscesses
- macrophages β M1 phenotype dominates in active colitis; failure to shift to M2 prevents resolution
- leaky gut β increased intestinal permeability both consequence and driver of colitis via antigen exposure
- gut barrier β epithelial integrity loss via tight junction disruption (claudin, occludin downregulation)
- microbiome β dysbiosis with loss of butyrate producers and expansion of adherent-invasive E. coli
- butyrate β SCFA deficiency removes histone deacetylase inhibition and Treg support
- inflammation β prototypical chronic inflammatory process with failed resolution
- resolution β deficient SPM production (resolvins, protectins) prevents inflammation termination
- specialized pro-resolving mediators β RvD1, RvD2, MaR1 supplementation therapeutic in colitis models
- NF-ΞΊB β master inflammatory transcription factor activated by TNF-Ξ± and IL-1Ξ²
- NLRP3 inflammasome β activated by barrier breach and microbial products; IL-1Ξ² source
- TLR4 β LPS receptor triggering innate immune activation upon barrier compromise
- brain-immune axis β bidirectional communication enabling immune memory storage and conditioned reactivation
- vagus nerve β efferent arm of cholinergic anti-inflammatory pathway; VNS therapeutic in colitis
- HPA axis β stress axis dysregulation contributes to colitis susceptibility and flares
- cortisol resistance β impaired glucocorticoid signaling in chronic inflammation prevents negative feedback
- calprotectin β fecal biomarker (neutrophil-derived S100A8/A9) quantifying intestinal inflammation severity
- peritonitis β companion model in immunoception research testing immune pattern specificity
- Crohn's disease β transmural IBD that may involve colon with similar but distinct pathophysiology